CD274 and familial pancreatic carcinoma: PD-L1 blockade failed to inhibit the growth of established Panc02-SIY tumors (Figure 3A), paralleling clinical observations where anti-PD-L1 therapy was ineffective in pancreatic cancer patients [2].